NCT01980706View on ClinicalTrials.gov

Efficacy and Safety of High Dose Baclofen for Alcohol Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 12, 2013

Primary Completion Date

October 26, 2017

Study Completion Date

October 26, 2017

Conditions
Alcoholism
Interventions
DRUG

Baclofen

Baclofen is a GABA-B agonist

DRUG

Placebo

Pill containing no pharmacologically active substance.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT01980706 - Efficacy and Safety of High Dose Baclofen for Alcohol Dependence | Biotech Hunter | Biotech Hunter